Wave Life Sciences Ltd. (NASDAQ:WVE) went up by 2.68% from its latest closing price compared to the recent 1-year high of $5.31. The company’s stock price has collected 26.43% of gains in the last five trading sessions.
Is It Worth Investing in Wave Life Sciences Ltd. (NASDAQ :WVE) Right Now?
Plus, the 36-month beta value for WVE is at -0.59. Opinions of the stock are interesting as 4 analysts out of 7 who provided ratings for Wave Life Sciences Ltd. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $7.86, which is $3.65 above the current price. WVE currently public float of 72.78M and currently shorts hold a 1.99% ratio of that float. Today, the average trading volume of WVE was 322.18K shares.
WVE’s Market Performance
WVE stocks went up by 26.43% for the week, with a monthly drop of -7.68% and a quarterly performance of 20.98%, while its annual performance rate touched 6.05%. The volatility ratio for the week stands at 11.40% while the volatility levels for the past 30 days are set at 12.12% for Wave Life Sciences Ltd. The simple moving average for the period of the last 20 days is 0.55% for WVE stocks with a simple moving average of 45.39% for the last 200 days.
Analysts’ Opinion of WVE
Many brokerage firms have already submitted their reports for WVE stocks, with H.C. Wainwright repeating the rating for WVE by listing it as a “Buy.” The predicted price for WVE in the upcoming period, according to H.C. Wainwright is $20 based on the research report published on December 15th of the previous year 2020.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see WVE reach a price target of $13. The rating they have provided for WVE stocks is “Sector Perform” according to the report published on October 23rd, 2020.
SVB Leerink gave a rating of “Mkt Perform” to WVE, setting the target price at $10 in the report published on December 31st of the previous year.
WVE Trading at 2.21% from the 50-Day Moving Average
After a stumble in the market that brought WVE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.72% of loss for the given period.
Volatility was left at 12.12%, however, over the last 30 days, the volatility rate increased by 11.40%, as shares sank -8.28% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +19.60% upper at present.
During the last 5 trading sessions, WVE rose by +26.43%, which changed the moving average for the period of 200-days by +71.14% in comparison to the 20-day moving average, which settled at $4.17. In addition, Wave Life Sciences Ltd. saw 34.08% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at WVE starting from RA CAPITAL MANAGEMENT, L.P., who purchase 9,480,052 shares at the price of $2.15 back on Jun 16. After this action, RA CAPITAL MANAGEMENT, L.P. now owns 17,202,009 shares of Wave Life Sciences Ltd., valued at $20,382,112 using the latest closing price.
Vargeese Chandra, the of Wave Life Sciences Ltd., sale 16,714 shares at $1.72 during a trade that took place back on May 05, which means that Vargeese Chandra is holding 111,095 shares at $28,748 based on the most recent closing price.
Stock Fundamentals for WVE
Current profitability levels for the company are sitting at:
- -310.07 for the present operating margin
The net margin for Wave Life Sciences Ltd. stands at -298.42.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.53.